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702 LettersFig 1. All defendants named in litigation related to soft-
tissue filler injections. Many of the lawsuits named multi-
ple defendants. Bar graph shows how physicians are the
most commonly charged in litigation regardless of who
performed the procedure.Litigation arising from the use of soft-tissue
fillers in the United States
To the Editor: With the increased use of soft-tissue
fillers, there has been a concomitant rise in litigation
assertingharmasa resultof treatments. In2013,nearly1
million soft-tissue filler procedures were performed.1,2
We sought to examine a legal database for litigation and
disciplinary actions involving soft-tissue fillers.
In July 2014, online public legal documents were
searched using the national legal research service
WestlawNext. We searched 3 database categories:
cases; trial court orders, and administrative guidance
and decisions. ‘‘Cases’’ contains opinions issued by
state and federal trial, appellate, and supreme courts.
‘‘Trial court orders’’ contains decisions by state trial
courts. ‘‘Administrative guidance and decisions’’
contains opinions from a variety of regulatory
agencies outside of the judicial branch, including
agencies that regulate physicians.
Fig 2. Specialty of dermal filler injectors who underwent litigation. Figure shows the largest
proportion of litigated cases were performed by nonphysicians. Most commonly litigated
physician subspecialties were plastic surgery and dermatology.
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Letters 703Our search terms were ‘‘dermal filler,’’ ‘‘cosmetic
injection,’’ ‘‘Zyderm,’’ ‘‘Zyplast,’’ ‘‘Cosmoderm,’’
‘‘Cosmoplast,’’ ‘‘Restylane,’’ ‘‘Perlane,’’ ‘‘Hylaform,’’
‘‘Belotero,’’ ‘‘Juvederm,’’ ‘‘Prevelle,’’ ‘‘Artefill,’’
‘‘Sculptra,’’ ‘‘Radiesse,’’ ‘‘Softform,’’ ‘‘Autologous fat,’’
‘‘Fascian,’’ ‘‘Elevess,’’ ‘‘Evolence,’’ ‘‘plastic surgeon,’’
‘‘dermatologist,’’ ‘‘physician,’’ ‘‘nonphysician,’’ ‘‘nurse
practitioner,’’ and ‘‘physician assistant.’’ Any litigation
or professional disciplinary action that did not
involve soft-tissue fillers was excluded; the first case
discovered was in 1995 and the last in 2013.
The total number of cases and disciplinary actions
definitely underreports the true incidence of legal
events as the search fails to detect cases (malpractice
and otherwise) that did not involve an appeal, were
settled, or were decided at the trial level and did not
involve a novel legal issue. Malpractice cases are
included but this database is not a comprehensive
source.
A total of 24 legal documents were identified: 19
cases and 5 disciplinary actions. Of the 19 cases,
physicians were named as defendants in 13 (Fig 1).
Six of the 7 cases that named a nonphysician as a
defendant involved a substance being injected
different than the reported filler. Overall, 50% of legal
actions from soft-tissue fillers were related to a
nonphysician performing the procedure. Of physi-
cian subspecialists, dermatologists and plastic sur-
geons had the highest proportion of litigation (17%
each) (Fig 2); this is likely due to these specialties
performing a higher volume of the relevant pro-
cedures.3-5 The majority of disciplinary actions werereprimanding physicians for not being present while
a nonphysician employee injected patients with soft-
tissue fillers. In 3of the 5 reprimands, physicianswere
functioning as medical directors of medical spas.
The most common injury stimulating litigation
was granuloma formation or other autoimmune
reaction. In our review, Zyderm was the soft-tissue
filler most commonly associated with litigation;
however, Zyderm was the first soft-tissue filler
approved and temporal bias likely explains the
higher number of associated cases.
The medico-legal culture is one where physicians
are responsible for their physician extenders. Further
research should evaluate whether the presence of a
physician affects rate of developing complications.
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